| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |